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http://dx.doi.org/10.1016/j.jmii.2012Background/Purpose: Splenic abscesses are uncommon. This study aimed at assembling the
demographics, clinical features, microbiologic etiologies, imaging, treatments, and outcomes
of patients with splenic abscesses at a tertiary medical center in northern Taiwan.
Methods: Thediagnosis of splenic abscesswasmadeeitherby imaging studies associatedwithclin-
ical symptoms and signs of infection, or by imaging studies associatedwithmicrobiological data or
pathologic results. The clinical characteristics, isolated pathogens, and treatments diagnosed at a
medical center in northern Taiwan between 2000 and 2011 were analyzed retrospectively.
Results: Of 28 patients with splenic abscess,male patients accounted for 46% of the study popula-
tion. Themeanage of the patients at the timeof presentationwas 46.5 years (range4months to 85
years). Common presentations were fever (71.4%, 20 cases), abdominal pain (46.4%, 13 cases),
cough or dyspnea (35.7%, 10 cases), splenomegaly (32.1%, 9 cases), and left-sided pleural effusion
(32.1%, 9 cases). Leukocytosis was noted in 22 patients (78.5%). Gram-negative bacilli and Gram-
positive cocci were cultivated from six patients (21%). No specific pathogen was predominant in
patients with splenic abscesses. The overall mortality was 14.3%, while the mortality among the
patients treated with antimicrobial therapy alone was 5.6%.
Conclusion: The survival rate was high in patients with splenic abscesses who received antimicro-
bial therapy alone. Percutaneous drainage can be used as an alternative choice for patients with
severe co-morbidities or patients who are critically ill.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.fectious Disease, Department of Medicine, Mackay Memorial Hospital, 92, Section 2, Zhongshan North
104, Taiwan, ROC.
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leukemia, 4 (14.3%) had end-stage kidney disease and wereSplenic abscesses are uncommon, with a prevalence of
0.14e0.7% in autopsy studies.1e3 Splenic abscesses gener-
ally occur in patients with splenic trauma, malignancies,
diabetes mellitus, immunodeficiency disorders, or systemic
infections.4e6 The diagnosed incidence of splenic abscesses
has increased over recent decades due to the increasing
number of immunocompromised patients and the wide-
spread use of imaging modalities such as computed
tomography (CT) and ultrasonography (US).4,7e9 The
management of splenic abscesses includes early diagnosis,
medical therapy with antimicrobial or antifungal agents,
and surgery or percutaneous drainage. The objective of the
current study was to report the clinical features, microbi-
ologic etiologies, treatments, and outcomes of patients
with splenic abscesses at a tertiary medical center in
northern Taiwan over the previous 12 years.
Materials and methods
Study design and data collection
The diagnosis of splenic abscess was made if one of the
following criteria was met: (1) causative pathogens were
isolated from a splenic aspirate or blood culture with
compatible imaging studies, such as US or CT; (2) histologic
examination of resected splenic tissue indicated the pres-
ence of an abscess; (3) there were operative findings of
a splenic abscess during exploratory laparotomy; and (4)
there were clinical manifestations and imaging findings
consistent with the condition and an improvement in the
patient’s clinical condition after antibiotic therapy. Leuko-
cytosis or leukopenia was defined as a peripheral white cell
count >10,000/mL or <4000/mL, respectively. All of the
medical charts were reviewed to collect data, including sex,
age, clinical manifestations, underlying diseases, imaging
studies, treatment course, isolated pathogens, and clinical
outcome. The patients were followed up for 6 months as an
end-point to determine the outcome.
Statistical analysis
A univariate analysis of prognostic factors for splenic
abscess (e.g., age, sex, abscess number, underlying
disease, microorganism, and treatment) was performed
using Fisher’s exact test. The mean age was evaluated using
the Wilcoxon rank-sum test.
Results
Between January 2000 and December 2011, 214 patients
with a diagnosis of suspected splenic abscess were
reviewed, and 28 met the criteria for splenic abscess. The
current study comprised 13 males and 15 females, with
a mean age of 46.5 years (range 4 months to 85 years). The
patients’ characteristics, age, sex, predisposing factors,
number of splenic abscesses, microbiologic etiologies,
treatments, and outcomes are shown in Table 1. Of the 28
patients, 7 (25%) had diabetes mellitus, 5 (17.9%) hadundergone previous abdominal surgery, 5 (17.9%) had
undergoing hemodialysis, 2 (7.1%) had HIV infection, 1
(3.6%) had cervical cancer, 1 (3.6%) had colon cancer, 1
(3.6%) suffered from systemic lupus erythematosus (SLE),
and 1 (3.6%) was an intravenous drug user.
Pathogens were not identified in 9 (32.1%) patients with
splenic abscesses. A fungal infection was suspected in
patient #15 based on the clinical condition and CT images.
Four patients were diagnosed with fungal infections clini-
cally, including patient #15, whose clinical condition
improved after treatment with antifungal agents. In our
study, six patients showed Gram-positive coccal infections
(2 streptococci, 1 enterococci, 2 Staphylococcus aureus, 1
Micrococcus), six had Gram-negative bacillary infections (3
nontyphoidal salmonellosis, 1 Klebsiella pneumoniae, 1
Pseudomonas aeruginosa), and one had a mixed infection.
Patient #27 had a presentation of intermittent fever for 2
weeks, and her family owned a dog and a cat as pets. She
usually slept with the cat, and cat scratches had occa-
sionally been noted. Bartonella henselae infection was
suggested by polymerase chain reaction on abscess fluid.
The patients’ clinical symptoms and signs included fever
(20 patients, 71.4%), diffuse abdominal pain (13 patients,
46.4%), cough or dyspnea (10 patients, 35.7%), and left upper
quadrant pain or tenderness (4 patients, 14.3%). Physical
examination revealed splenomegaly in nine (32.1%) patients.
Chest radiographs showed left-sided pleural effusions in nine
(32.1%) patients. Leukocytosis was noted in 22 (78.5%)
patients. Two patients with acute lymphocytic leukemia had
febrile neutropenia 1e2 weeks after chemotherapy.
All patients underwent abdominal US and/or CT; Five
patients had abdominal US and CT, 11 abdominal US alone,
and 12 abdominal CT alone. A single abscess was noted in 14
(50%) patients and multiple abscesses in 14 (50%) patients
(Table 1).
The prognostic factors for splenic abscess are shown in
Table 2. Antimicrobial therapy was instituted in all
patients. Eighteen (64.3%) patients recovered under
medical treatment. Four (14.3%) patients underwent sple-
nectomy and were discharged with oral antibiotics, and
four (14.3%) patients received percutaneous drainage of
their splenic abscess.
The overall mortality rate was 14.3% (4 patients), and
the mortality rate in those receiving medical therapy was
5.6% (1 patient) (Table 2). All four patients who received
medical treatment and splenectomy survived, but two
(40%) of the five patients who had medical treatment and
percutaneous drainage died.
Brief summaries of the four patients who died are as
followed. Patient #28, who had underlying SLE, initially
received antibiotics, but her symptoms persisted. She then
twice underwent percutaneous drainage, but due to inad-
equate drainage a splenectomy was performed. However,
she died of massive intraoperative bleeding. Patient #23
with chronic kidney disease, cervical cancer, and
methicillin-resistant Staphylococcus aureus septicemia was
initially treated with teicoplanin, but 22 days later
abdominal CT revealed multiple abscesses in the spleen,
perianal area, bilateral psoas muscles, and left hip. Despite
their drainage, the patient died 15 days later. Liver and
splenic abscesses were present in Patient #19, but she died
Table 1 Demographics, management, and outcomes of patients with splenic abscess
Case number Sex Age (years) Predisposing factors Number of
abscesses
Microbiological etiology and diagnosis Treatment Outcome
1 M 49 Alcoholic liver cirrhosis Single Not identified AT Recovered
2 F 31 AIDS (CD4 count 7 cells/mL,
viral load 4020 copies/mL)
Multiple Mycobacterium avium intracellulare
complex (sputum and lymph node)
AT Recovered
3 M 67 ESRD, HTN Multiple Not identified AT Recovered
4 F 62 Postcholecystectomy Single Not identified AT Died
5 M 63 Liver cirrhosis, DM Single Not identified AT Recovered
6 F 73 Cervical cancer, old TB,
liver cirrhosis, HTN
Multiple Not identified AT Recovered
7 M 83 ESRD, HTN Single Not identified AT Recovered
8 M 34 IDU Single Staphylococcus aureus (blood) AT Recovered
9 F 83 Polycystic liver disease,
postcholecystectomy
for gallbladder stones
Single Not identified AT Recovered
10 F 28 DM, ESRD Multiple Pseudomonas aeruginosa (blood) AT Recovered
11 M 85 Colon cancer, DM 2 Not identified AT Recovered
12 M 59 CML, HTN Single Nontyphoidal Salmonella (blood) AT Recovered
13 M 25 HIV (CD4 count 286 cells/mL,
viral load 39,898 copies/mL)
Multiple Mycobacterium tuberculosis
(sputum, neck lymph node)
AT Recovered
14 F 4 months Biliary atresia e
post-Kasai’s operation
Single Micrococcus species (blood) AT Recovered
15 M 51 AML, DM Multiple Suspected fungus, blood
cryptococcal antigen titer: 1:2
Antifungal agents Recovered
16 F 19 ALL Multiple Blastochizomyces species (blood) Antifungal agents Recovered
17 F 2 ALL Multiple Penicillium species (blood) Antifungal agents Recovered
18 M 3 ALL Multiple Candida tropicalis,
nontyphoidal Salmonella (blood)
AT þ antifungal agents Recovered
19 F 84 HTN 3 Gamma-hemolytic group D
Streptococcus (abscess)
AT þ PD Died
20 F 50 DM, HTN, ESRD Single Bacteroides fragilis,
Peptostreptococcus (abscess)
AT þ PD (3 times) Recovered
21 M 35 DM, chronic pancreatitis, HTN Single Klebsiella pneumoniae (blood) AT þ PD Recovered
22 M 65 DM Single Viridans streptococci (blood, abscess) AT þ PD Recovered
23 F 66 Unknown Multiple Methicillin-resistant
Staphylococcus aureus (blood, abscess)
AT þ PD Died
24 F 78 Unknown Multiple Not identified AT þ ST Recovered
25 F 46 Gastric ulcer, duodenal ulcer Single Citrobacter freundii,
Proteus mirabilis, Klebsiella pneumoniae,
Enterococcus
AT þ ST Recovered
26 M 1 Duplication cyst of duodenum Single Nontyphoidal Salmonella (abscess) AT þ ST Recovered
27 F 9 Unknown Multiple Bartonella henselae AT þ ST Recovered
28 F 50 SLE Single VRE (blood), Enterococcus species (abscess) AT þ PD þ ST Died
ALL Z acute lymphoblastic leukemia; AML Z acute myeloid leukemia; AT Z antibacterial therapy; CML Z chronic myeloid leukemia; DM Z diabetes mellitus; ESRD Z end-stage renal
disease; HIVZ human immunodeficiency virus; HTNZ hypertension; IDUZ intravenous drug use; PDZ percutaneous drainage; SLEZ systemic lupus erythematosus; STZ splenectomy;
TB Z tuberculosis; VRE Z vancomycin-resistant Enterococcus.
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Table 2 Prognostic factors for splenic abscess
Variable Category (n) Outcome: cure
(N Z 24) (n, %)
Outcome: fatal
(N Z 4) (n, %)
p
Sex Female (15) 11 (73.3) 4 (26.7) 0.10*
Male (13) 13 (100) 0 (0)
Number of abscesses Solitary (14) 12 (85.7) 2 (14.3) 1.00*
Multiple (14) 12 (85.7) 2 (14.3)
Underlying disease Without (4) 2 (50) 2 (50) 0.09*
With (24) 22 (91.7) 2 (8.3)
Diabetes mellitus Without (21) 17 (81) 4 (19) 0.54*
With (7) 7 (100) 0 (0)
Microorganism GNB (6) 6 (100) 0 (0) 0.15*
GPC (6) 3 (50) 3 (50)
GNB þ GPC (1) 1 (100) 0 (0)
Fungus (4) 4 (100) 0 (0)
Sterile (9) 8 (88.9) 1 (11.1)
Age Mean  SD 43.3  28.3 65.5  14.1 0.16**
Median 47.5 64.0
Treatment AT þ ST (4) 4 (100) 0 (0) 0.04*
AT þ PD (5) 3 (60) 2 (40)
AT or antifungal alone (18) 17 (94.4) 1 (5.6)
AT þ PD þ ST (1)a 0 (0) 1 (100)
* Fisher’s exact test.
** Wilcoxon rank-sum test.
AT Z antimicrobial therapy; GNB Z Gram-negative bacilli; GPC Z Gram-positive cocci; ST Z splenectomy; PD Z percutaneous
drainage; SD Z standard deviation.
a A fatal case with antimicrobial therapy, percutaneous drainage and later splenectomy.
Splenic abscess in northern Taiwan 107of septic shock. In Patient #4, cellulitis involving left face
and left abdominal pain comprised the initial presentation.
Surgery was initially deferred, and the sepsis progressed
despite appropriate antibiotics.
Discussion
Splenic abscesses are uncommon, occurring in 0.14e0.7% of
autopsy studies.1e3 Discussions pertaining to splenic
abscesses are usually limited to case reports or institutional
studies. In one study of 501 patients with 540 intra-abdominal
abscesses, no splenic abscesses were reported.10 The causes
of splenic infections have mostly been systemic infections,
contiguous infections, infections secondary to splenic
infarction, and traumatic injuries involving the spleen.3,7
Immunodeficiency is a major factor underlying splenic
abscesses. With the increasing prevalence of malignancies,
organ transplantation, and immunosuppressive therapy, the
risk of splenic abscesses has increased.7,11 In a review
involving 287 patients with splenic abscesses, 33.5% of
cases had an immunosuppressed state, and nearly half had
underlying intravenous drug abuse and AIDS.3 In the current
study, 60.7% of 28 patients had immunodeficiency disor-
ders, such as HIV/AIDS, end-stage kidney disease, hema-
tologic malignancies, solid organ malignancies, SLE,
intravenous drug abuse, or liver cirrhosis, suggesting that
immunodeficiency is a predisposing risk factor for splenic
abscesses. However, because of small patient number in
the current study, more studies are warranted.
The mortality rate of splenic abscesses ranged between
13% and 25%.3,4,12 The overall mortality rate in our study was
14.3%, in agreement with that of previous studies.3,4,12 Themortality rate of our patients with immunodeficiency disor-
ders may be underestimated as a result of the exclusion of
the patients who died without pathogens being identified. In
these patients, it was difficult to differentiate splenic lesions
in patients with systemic infections from infarctions or
infections.7 Therefore, the case number and mortality rate
of splenic abscesses might be being underestimated.
The most common organisms in most series involving
splenic abscesses were aerobic microbes, especially
staphylococci, streptococci, Salmonella, and Escherichia
coli.3,5,13 Mycobacterium tuberculosis was the most
common microorganism in a retrospective study of 22 cases
in a single institution in Spain, where all patients with
tuberculous abscess in spleen had AIDS.13 In Taiwan, Kleb-
siella pneumoniae was the major pathogen in patients with
liver abscesses. Among splenic abscess caused by Gram-
negative bacilli in Taiwan, Klebsiella pneumoniae was the
most common pathogen, with a higher prevalence in dia-
betic patients and a higher incidence in patients with
concomitant liver abscesses.4,7,12,14
The treatment options for splenic abscesses include
antimicrobial therapy, percutaneous drainage, and sple-
nectomy. During the 20th century, the use of intravenous
antimicrobial therapy alone resulted in a high mortality
rate (100%).3 However, with improvements in imaging
technology and the production of new antibiotics, the
mortality rate of individuals treated with antimicrobial
therapy alone has decreased over time. Successful treat-
ment rates of 75% with antimicrobial therapy alone were
mentioned in a study of 29 cases in a single institution in
Taiwan.11 More than 60% of our patients received medical
therapy alone, the major therapeutic modality in the
Table 3 Comparison of epidemiology and symptoms among four studies
Variable Chun et al Nelken et al Ooi & Leong Our study
1900e1977 1977e1986 1987e1995 2000e2011
Number of cases 173 189 287 28
Male:female 1.7:1 1.95:1 2.04:1 0.87:1
Age, mean (y) 36.8 Not available 41.4 46.5
Age range 6 mo e 83 y 6 mo e 82 y 6 mo e 92 y 4 mo e 85 y
Clinical symptoms and signs
Fever (n, %) 145/152 (95.4) 131/156 (84) 246/171 (90.8) 20/28 (71.4)
Left upper quadrant pain (n, %) 64/152 (42.1) 61/156 (39) 126/253 (49.8) 4/28 (14.3)
Splenomegaly (n, %) 82/152 (53.9) 62/156 (40) 79/257 (30.7) 9/28 (32.1)
Left-sided pleural effusion (n, %) 34/173 (19.7) Not available 57/256 (22.3) 9/28 (32.1)
The table was modified according to Ooi and Leong (1997).1e3
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a favorable outcome, the result being better than those
previously reported.3,7,11,12,14
Although intravenous antimicrobial therapy with splenec-
tomyhas been regarded as the treatment of choice for splenic
abscess by some experts,3,5 percutaneous drainage has been
reported to be a reliable technique with a high success rate in
patients with splenic abscesses, and costs less than surgery.9
Moreover, percutaneous drainage can be an alternative
choice for critically ill patients and for youngpatients inwhom
attempts are made to preserve the spleen.7,12e14 Percuta-
neous drainage is consideredwhen the abscess is unilocular or
bilocular with a discretewall and no internal septa, andwhen
the liquid content can be drained.13 Our patients treatedwith
antibiotics and splenectomy had an optimal outcome, but as
the sample sizewas small, more clinical experience is needed
to draw any conclusion. With the advent of broad-spectrum
antibiotics and imaging modalities, the mortality rate could
be expected to be lower than previously.
A comparison of the epidemiology and symptoms in
three published reports is shown in Table 3. In previous
studies, males comprised 63e67% of the patients with
splenic abscesses, which was greater than the proportion
seen in the current study (46%); the small number of cases
here could be one of the reasons for this difference.1e3
In conclusion, splenic abscesses should be suspected in
immunosuppressed patients in the presence of unexplained
fever with associated symptoms and signs of abdominal
pain, especially in left upper quadrant, and suggestive
radiologic findings. A good prognosis was noted in the
patients with splenic abscesses receiving antimicrobial
therapy alone. However, percutaneous drainage can be
used as an alternative choice for patients with severe co-
morbidities or those who are critically ill.
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